spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

ISO 45001: Global occupational safety and health are important to Gerresheimer

Gerresheimer AG


Düsseldorf, June 30,2020: The Gerresheimer Group has declared DIN EN ISO 45001 to be the mandatory global standard for all its plants. It replaces thepreviously applicable standard OHSAS 18001in the field of occupational health and safety.

"For Gerresheimer, healthy and motivated employees are the key to sustained economic success. We want all employees worldwide to go home exactly as healthy and unharmed as they came to work," says Katja Schnitzler, who as Group Senior Director EHS CSR OPEX is responsible for managing global implementation.

Evenmore safety in the workplace
ISO 45001 will become the international standard in occupational safety and health protection for the entire Gerresheimer Group. At the same time, the company wants to show that it is living up to its social responsibility by achieving internationally recognized ISO 45001 certification. Gerresheimer makes every effort to demonstrably reduce the risk of injuries, accidents and work-related illnesses among its employees and is constantly improving occupational safety and health protection using suitable methods and instruments as part of itsmanagement system. ISO 45001 was published in March 2018 and will replace the previously most widely used standard BS OHSAS 18001. Gerresheimer employs employees at each location who are responsible for occupational safety and health.

Gerresheimer on the way to ISO 45001
The first Gerresheimer plants in Europeand Asiaare currently certified. At most plants the measures for the forthcoming certification have been successfully launched or are nearing completion.The following plants have already received their certificate.

China:The Chinese plants of the Shuangfeng Group, i.e. Danyang I and II and Zhenjiang, which have been successfully producing glass containers for the pharmaceutical industry in China for decades, have beencertified to ISO 45001 since 2018.

Denmark:Only recently the Gerresheimer plantsin Vaerloese and Haarby havesuccessfully completed their certification. At these plants primary packaging made of plasticof the well-known brands Duma and Dudek is produced.

India:In India, the plants in Kundli, which produces plastic containers, and the plant in Kosamba, wherevials and ampoules made of tubular glass are produced, have currently received certification. The plant for the production of container glass in Kosamba is currently preparing forcertification.

Germany: The German Medical Systems plants in Pfreimd, Wackersdorf, Regensburg and Bünde, as well as in Horsovsky Tyn in the Czech Republic, are already working with an Integrated Management System that has already certified the areas of environmental protection and energy management and also covers occupational health and safety standards. Fire protection also meets the legal requirements and applies in all MDS plants. The next important step is the implementation of the new ISO 45001 standard based on the Integrated Management System.

About Gerresheimer
Gerresheimer is a leading global partner to the pharma and healthcare industry. With special products made of glass and plastic the company contributes to health and well-being. Gerresheimer is represented worldwide and with around 10,000 employees produces where its customers and markets are. With plants in Europe, America and Asia Gerresheimer generates sales of around €1.4 billion. The wide range of products includes pharmaceutical packaging and products for simple and safe drug administration: Insulin pens, inhalers, micropumps, prefillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medications with closure and safety systems, as well as packaging for the cosmetics industry.
phone +49-(0)211/61 81-00
email info@gerresheimer.com
web www.gerresheimer.com
email Klaus-Bungert-Str. 4, 40468 Duesseldorf, Germany
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Leading pharma packaging companies commit to supply for Covid-19 fight

The CEOs of Gerresheimer, Stevanato Group, and SCHOTT are committed to ensuring ample supply of pharmaceutical containers for any Covid-19 vaccine and treatment that is developed, and that no patient shall be left behind, no matter what region of the world they live in. Also, the companies will make every effort to support the pharma industry’s’ priorities for overall medication supply in addition to Covid-19 drugs. Each of the three companies manufactures billions of type-1 borosilicate glass vials, the most proven and most widely available material used to store and deliver vaccines around the world. They are making the statement to provide confidence in the global pharmaceutical supply chain in times of uncertainty.
More info >>


White Papers

Working Towards a Standardised Identification Solution

PCI Pharma Services

The security of the pharmaceutical supply chain is an issue of growing concern, with recent reports addressing its vulnerability to counterfeiting. The complexity of the European supply chain is one of the key factors of this counterfeiting pandemic, with millions of medicine packs being moved around the EU, annually. Aside from this, fragmentation has resulted in decreased transparency in the supply chain and increased difficulties to track and trace medicines, leading to significant threat from counterfeiting. As a key source of income for the European economy, it is essential that the supply chain remains safe and free of counterfeits. A significant stumbling block within the industry remains to be the lack of a unified, single‐source pan‐European or indeed global database where scanned bar codes on drug packaging can be verified at point of dispense. At some point in the future the pharmaceutical industry, regulatory bodies, clinicians and retailers will need to join forces to overcome this.
More info >>

Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement